Imaging Biometrics Ltd. (LON:IBAI)

Market Cap	1.73M -12.5%
Revenue (ttm)	788.15K +5.1%
Net Income	-400.94K
EPS	-0.00
Shares Out	246.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	213,815
Open	0.7500
Previous Close	0.7000
Day's Range	0.7000 - 0.7500
52-Week Range	0.4000 - 1.4000
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-chip segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic; IB Neuro, a MRI perfusion platform that generates quantitative relative cerebral blood volume maps...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 1965
• Employees: 7
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IBAI

Financial Performance

In 2025, Imaging Biometrics's revenue was 788,148, an increase of 5.07% compared to the previous year's 750,105. Losses were -400,940, 22.6% more than in 2024.